Drug Trial Radar · NCT03511846
Pain Biomarker Study
Last checked: Nov 20, 2026Latest source record: Feb 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
371
Planned (sponsor's estimate)
Start
Mar 21, 2018
Primary completion
May 31, 2028
Study completion May 31, 2028
Sponsor
- Lead sponsor
- The University of Texas Health Science Center, HoustonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of California, San Francisco
- First posted
- Apr 30, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study investigates molecular and physical biomarkers of headaches in order to better understand mechanisms of these diseases. There are 3 main parts: 1. Use of capsaicin (active ingredient in hot chili peppers) to trigger release of calcitonin gene related peptide - the hypothesis is that this will be different in headache subjects compared to controls (and if so might be used to predict how these patients will respond to certain medications that modulate calcitonin gene-related peptide). Subjects will be given capsaicin as a cream applied to the forehead or the inner nostril, or a hot sauce that is ingested. 2. Use of capsaicin to trigger eye watering - the hypothesis is that oxygen gas will slow down the amount of eye watering. Cluster headache patients respond very powerfully to oxygen gas but to very little else. The mechanism for oxygen is unknown but in rodents there is data that it works on the parasympathetic / lacrimal gland system. This study translates rodent data into humans in a non-invasive way to confirm the mechanism of this very effective treatment. 3. Use of ice water to trigger headaches - brain freeze causes a very short-lived but intense headache that may cause similar biomarker release as other headache disorders. This may be a useful human model for other headache disorders.
Conditions
- Migraine
- Cluster Headache
- Trigeminal Autonomic Cephalgia
- Hemicrania Continua
- Paroxysmal Hemicrania
- SUNCT
- Short-Lasting Unilateral Neuralgiform Headache With Conjunctival Injection and Tearing
Interventions
Oral capsaicinDrug
Subjects will drink a solution with capsaicin
Topical capsaicinDrug
Capsaicin cream will be applied to the skin of the forehead, cheek, or leg
Intranasal capsaicinDrug
Capsaicin cream will be applied to the nostril
Cold Water IrrigationOther
Subjects will be asked to drink up to 2000 ml of cold water or ice water (temperature 0-10 degrees Celsius) as fast as possible, either continuously or intermittently (i.e. 200-800 ml at a time)
Medical AirOther
Subjects will be exposed to medical air
Low Flow OxygenDrug
Subjects will be exposed to oxygen gas between 1-9 L/min
High Flow OxygenDrug
Subjects will be exposed to oxygen gas between 10-25 L/min
Primary outcomes
What the sponsor says the trial is designed to measure.
- Activation of trigeminoautonomic reflex as assessed by change in Calcitonin gene-related peptide (CGRP) levels from before stimulation to after stimulation.Time frame: 10 minutes before pain stimulation and 10 minutes, 20 minutes, 30 minutes, 60 minutes, and 90 minutes after pain stimulation
- Activation of trigeminoautonomic reflex as assessed by tear fluid productionTime frame: 90 minutes after pain stimulation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The University of Texas Health Science Center at Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.